{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T16:15:18Z","timestamp":1773591318378,"version":"3.50.1"},"reference-count":62,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Biology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1080\/13880209.2021.1915340","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:54:24Z","timestamp":1619571264000},"page":"470-481","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis"],"prefix":"10.1080","volume":"59","author":[{"given":"Chuihua","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Weifang People\u2019s Hospital, Weifang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Dong","sequence":"additional","affiliation":[{"name":"Infection Control Office, Weifang People\u2019s Hospital, Weifang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Weifang People\u2019s Hospital, Weifang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenni","family":"Gao","sequence":"additional","affiliation":[{"name":"Dispensing Room for Intravenous Transfusion, Weifang People's Hospital, Weifang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.188314"},{"key":"e_1_3_4_3_1","first-page":"54","article-title":"Application of Kangai injection for the treatment of moderate and advanced primary liver cancer","volume":"9","author":"Bao LQ.","year":"2007","unstructured":"Bao LQ. 2007. Application of Kangai injection for the treatment of moderate and advanced primary liver cancer. J Hubei Coll Trad Chin Med. 9:54\u201355.","journal-title":"J Hubei Coll Trad Chin Med"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_3_4_5_1","first-page":"142","article-title":"Curative effect observation of Kangai combined with chemotherapy for the treatment of advanced liver cancer","volume":"10","author":"Cai SH.","year":"2013","unstructured":"Cai SH. 2013. Curative effect observation of Kangai combined with chemotherapy for the treatment of advanced liver cancer. Chin Foreign Health Abstr. 10:142\u2013143.","journal-title":"Chin Foreign Health Abstr"},{"key":"e_1_3_4_6_1","first-page":"2916","article-title":"Therapeutic effect of entecavir combined with traditional Chinese medicine injection on advanced liver cancer patients complicated with hepatitis B virus infection and impact on prognosis","volume":"27","author":"Cai F","year":"2017","unstructured":"Cai F, Wu CR, Zhang XY, Wan YJ, Cai X. 2017. Therapeutic effect of entecavir combined with traditional Chinese medicine injection on advanced liver cancer patients complicated with hepatitis B virus infection and impact on prognosis. Chin J Nosocomiol. 27:2916\u20132919.","journal-title":"Chin J Nosocomiol"},{"key":"e_1_3_4_7_1","first-page":"2400","article-title":"Clinical curative effect observation of Kangai injection in the treatment of primary liver cancer","volume":"33","author":"Cao J","year":"2008","unstructured":"Cao J, Gu H, Ayi FH, Tai QW, Zhang JH. 2008. Clinical curative effect observation of Kangai injection in the treatment of primary liver cancer. China J Chin Mater Med. 33:2400\u20132401.","journal-title":"China J Chin Mater Med"},{"key":"e_1_3_4_8_1","first-page":"39","article-title":"Clinical effect of Kangai injection combined with chemotherapy in the treatment of cancer-related fatigue of hepatocellular carcinoma patients","volume":"15","author":"Chen ZC.","year":"2017","unstructured":"Chen ZC. 2017. Clinical effect of Kangai injection combined with chemotherapy in the treatment of cancer-related fatigue of hepatocellular carcinoma patients. Inter J Ttranspl Hemopurif. 15:39\u201341.","journal-title":"Inter J Ttranspl Hemopurif"},{"key":"e_1_3_4_9_1","first-page":"182","article-title":"Observation of advanced hepatocellular carcinoma chemotherapy effect of Kang\u2019ai injection","volume":"8","author":"Cheng X","year":"2016","unstructured":"Cheng X, Yang J, Meng Y. 2016. Observation of advanced hepatocellular carcinoma chemotherapy effect of Kang\u2019ai injection. China Cont Med Educ. 8:182\u2013184.","journal-title":"China Cont Med Educ"},{"key":"e_1_3_4_10_1","first-page":"124","article-title":"Effect of Kang\u2019ai injection combined with entericavir on antiviral effect and liver function in patients with advanced liver cancer","volume":"27","author":"Cheng C","year":"2019","unstructured":"Cheng C, Zheng RF. 2019. Effect of Kang\u2019ai injection combined with entericavir on antiviral effect and liver function in patients with advanced liver cancer. Clin Res. 27:124\u2013126.","journal-title":"Clin Res"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31937"},{"key":"e_1_3_4_13_1","first-page":"73","article-title":"Clinical observation on improving life quality of advanced liver cancer patients with the Kang\u2019ai injection","volume":"8","author":"Fu J.","year":"2016","unstructured":"Fu J. 2016. Clinical observation on improving life quality of advanced liver cancer patients with the Kang\u2019ai injection. Clin J Chin Med. 8:73\u201375.","journal-title":"Clin J Chin Med"},{"key":"e_1_3_4_14_1","first-page":"62","article-title":"A case-control study of Kangai injection combined with transcatheter arterial chemoembolization in the treatment of primary liver cancer","volume":"13","author":"Fu H","year":"2009","unstructured":"Fu H, Yang L, Liu XH, Li XB. 2009. A case-control study of Kangai injection combined with transcatheter arterial chemoembolization in the treatment of primary liver cancer. J Clin Med Pract. 13:62\u201365.","journal-title":"J Clin Med Pract"},{"key":"e_1_3_4_15_1","first-page":"124","article-title":"To analyze the clinical effect of the treatment of advanced hepatocellular carcinoma TACE joint Kangai injection","volume":"7","author":"He S.","year":"2015","unstructured":"He S. 2015. To analyze the clinical effect of the treatment of advanced hepatocellular carcinoma TACE joint Kangai injection. Clin J Chin Med. 7:124\u2013125.","journal-title":"Clin J Chin Med"},{"key":"e_1_3_4_16_1","first-page":"75","article-title":"The effect of Kangai injection on serum tumor related substances and alpha fetoprotein in patients with liver cancer","volume":"28","author":"Huang JM.","year":"2018","unstructured":"Huang JM. 2018. The effect of Kangai injection on serum tumor related substances and alpha fetoprotein in patients with liver cancer. China Health Care Nutrit. 28:75.","journal-title":"China Health Care Nutrit"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8423037"},{"key":"e_1_3_4_18_1","first-page":"8","article-title":"Clinical observation on Kang\u2019ai injection in improving life quality of 35 patients with advanced liver cancer","volume":"41","author":"Huang ZR","year":"2010","unstructured":"Huang ZR, Yang AL, Wang RP, Ye YD. 2010. Clinical observation on Kang\u2019ai injection in improving life quality of 35 patients with advanced liver cancer. Fujian J Tradit Chin Med. 41:8\u20139.","journal-title":"Fujian J Tradit Chin Med"},{"key":"e_1_3_4_19_1","first-page":"1380","article-title":"Effects of Kangai injection combined with chemotherapy and embolization on advanced hepatocellular carcinoma and its effect on blood coagulation function and serum VEGF","volume":"20","author":"Huang W","year":"2014","unstructured":"Huang W, Zeng RX, Zhong H, Wang YJ, Luo Q, Chuan DM, Chen LC, Qing X, Zhang ZJ. 2014. Effects of Kangai injection combined with chemotherapy and embolization on advanced hepatocellular carcinoma and its effect on blood coagulation function and serum VEGF. J Hainan Med Univer. 20:1380\u20131382.","journal-title":"J Hainan Med Univer"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5453"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2020.1799040"},{"key":"e_1_3_4_22_1","first-page":"1468","article-title":"Application value of Kangai injection on advanced primary liver cancer palliative therapy","volume":"21","author":"Jin GX","year":"2014","unstructured":"Jin GX, Jin S, Sun WJ, Ji HX, Liu Y. 2014. Application value of Kangai injection on advanced primary liver cancer palliative therapy. Chin J Clin Onco Rehab. 21:1468\u20131470.","journal-title":"Chin J Clin Onco Rehab"},{"key":"e_1_3_4_23_1","first-page":"92","article-title":"Observation of Kang\u2019ai-injection on quality of life in patients with hepatocellular carci-noma after TACE","volume":"23","author":"Kang SL","year":"2015","unstructured":"Kang SL, Rao ZG, Yang B. 2015. Observation of Kang\u2019ai-injection on quality of life in patients with hepatocellular carci-noma after TACE. J Modern Onco. 23:92\u201394.","journal-title":"J Modern Onco"},{"key":"e_1_3_4_24_1","first-page":"289","article-title":"Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer","volume":"107","author":"Li QS","year":"1994","unstructured":"Li QS, Cao SH, Xie GM, Gan YH, Ma HJ, Lu JZ, Zhang ZH. 1994. Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer. Chin Med J. 107:289\u2013294.","journal-title":"Chin Med J"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.31928"},{"key":"e_1_3_4_26_1","first-page":"515","article-title":"The effect of Kang\u2019ai injection in patients with hepatocellular carcinoma treated with TACE combined with MWA","volume":"15","author":"Li HF","year":"2017","unstructured":"Li HF, Xu Q, Shen YF, Jiang MH, Lu DB. 2017. The effect of Kang\u2019ai injection in patients with hepatocellular carcinoma treated with TACE combined with MWA. Onco Prog. 15:515\u2013517.","journal-title":"Onco Prog"},{"key":"e_1_3_4_27_1","first-page":"3375","article-title":"Effect of Kangai injection combined with transcatheter arterial chemoembolization on coagulation function and serum VEGF in patients with advanced liver cancer","volume":"26","author":"Li D","year":"2017","unstructured":"Li D, Zhao F, Wang SG. 2017. Effect of Kangai injection combined with transcatheter arterial chemoembolization on coagulation function and serum VEGF in patients with advanced liver cancer. Modern J Integr Trad Chin West Med. 26:3375\u20133377.","journal-title":"Modern J Integr Trad Chin West Med"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/biom.12817"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joim.2018.05.002"},{"key":"e_1_3_4_30_1","first-page":"30","article-title":"Clinical observation of Kang'ai injection on advanced liver cancer with chemotherapy","volume":"9","author":"Liu ZH.","year":"2011","unstructured":"Liu ZH. 2011. Clinical observation of Kang'ai injection on advanced liver cancer with chemotherapy. Guide China Med. 9:30\u201331.","journal-title":"Guide China Med"},{"key":"e_1_3_4_31_1","first-page":"19","article-title":"Clinical observation of Kang\u2019ai-injection with TACE in 34 patients with hepatocellular carcinoma (HC)","volume":"18","author":"Liu HQ","year":"2007","unstructured":"Liu HQ, Chen SX, Li Y, Huang RW. 2007. Clinical observation of Kang\u2019ai-injection with TACE in 34 patients with hepatocellular carcinoma (HC). Hainan Med. J. 18:19\u201320.","journal-title":"Hainan Med. J"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20193319"},{"key":"e_1_3_4_33_1","first-page":"2655","article-title":"Clinical effect observation of Kangai injection combined with TACE in the treatment of primary liver cancer","volume":"32","author":"Lu YX","year":"2007","unstructured":"Lu YX, Huang DP, Hou NC, Qin B, Huang Y. 2007. Clinical effect observation of Kangai injection combined with TACE in the treatment of primary liver cancer. China J Chin Mater Med. 32:2655\u20132656.","journal-title":"China J Chin Mater Med"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.08.055"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-017-0512-0"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"e_1_3_4_37_1","first-page":"1991","article-title":"Antiviral effect analysis of entecavir combined with Kangai injection and effect on the improvement of liver function in patients with advanced liver cancer","volume":"26","author":"Ning Y.","year":"2017","unstructured":"Ning Y. 2017. Antiviral effect analysis of entecavir combined with Kangai injection and effect on the improvement of liver function in patients with advanced liver cancer. Modern J Integr Trad Chin West Med. 26:1991\u20131993.","journal-title":"Modern J Integr Trad Chin West Med"},{"key":"e_1_3_4_38_1","first-page":"513","article-title":"The effect of Kangai injection combined with lamivudine on the therapeutic effect and liver function of patients with advanced liver cancer and HBV infection after transcatheter arterial chemoembolization","volume":"16","author":"Shi XG.","year":"2019","unstructured":"Shi XG. 2019. The effect of Kangai injection combined with lamivudine on the therapeutic effect and liver function of patients with advanced liver cancer and HBV infection after transcatheter arterial chemoembolization. Anti-Infect Pharm. 16:513\u2013515.","journal-title":"Anti-Infect Pharm"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015987"},{"key":"e_1_3_4_40_1","first-page":"121","article-title":"Therapeutic effect observation of Kangai injection combined with chemotherapy for patients with moderate and advanced liver cancer","volume":"11","author":"Shu JZ.","year":"2013","unstructured":"Shu JZ. 2013. Therapeutic effect observation of Kangai injection combined with chemotherapy for patients with moderate and advanced liver cancer. Seek Med Ask Med. 11:121\u2013122.","journal-title":"Seek Med Ask Med"},{"key":"e_1_3_4_41_1","first-page":"47","article-title":"Progress in clinical application of Kangai injection","volume":"14","author":"Song WX","year":"2014","unstructured":"Song WX, Chen M, Cheng MJ, Zhang Z. 2014. Progress in clinical application of Kangai injection. Mod Hosp. 14:47\u201352.","journal-title":"Mod Hosp"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022148"},{"key":"e_1_3_4_43_1","first-page":"113","article-title":"The clinical effect of Kangai injection combined with entecavir in the treatment of HBV related advanced liver cancer and its effect on liver function","volume":"37","author":"Sun YN.","year":"2017","unstructured":"Sun YN. 2017. The clinical effect of Kangai injection combined with entecavir in the treatment of HBV related advanced liver cancer and its effect on liver function. Chin J Critic Care Med. 37:113\u2013114.","journal-title":"Chin J Critic Care Med"},{"key":"e_1_3_4_44_1","first-page":"29","article-title":"Clinical observation of Kangai injection in improving the quality of life of patients with advanced liver cancer","volume":"14","author":"Sun ZG.","year":"2017","unstructured":"Sun ZG. 2017. Clinical observation of Kangai injection in improving the quality of life of patients with advanced liver cancer. J North Pharm. 14:29.","journal-title":"J North Pharm"},{"key":"e_1_3_4_45_1","first-page":"46","article-title":"Clinical observation on 32 cases of primary liver cancer treated by Kangai injection combined with TACE","volume":"8","author":"Tian H","year":"2013","unstructured":"Tian H, He ZK, Xu QJ. 2013. Clinical observation on 32 cases of primary liver cancer treated by Kangai injection combined with TACE. Nat Med Front China. 8:46\u201347.","journal-title":"Nat Med Front China"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201601967"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/1534735417734913"},{"key":"e_1_3_4_48_1","first-page":"41","article-title":"Clinical observation of Kangai injection in the treatment of moderate advanced liver cancer","volume":"18","author":"Wang KS.","year":"2010","unstructured":"Wang KS. 2010. Clinical observation of Kangai injection in the treatment of moderate advanced liver cancer. China\u2019s Naturopathy. 18:41\u201342.","journal-title":"China\u2019s Naturopathy"},{"key":"e_1_3_4_49_1","first-page":"874","article-title":"Response of Kang-ai injection in palliative treatment for advanced primary hepatocellular carcinoma","volume":"21","author":"Wang WR.","year":"2012","unstructured":"Wang WR. 2012. Response of Kang-ai injection in palliative treatment for advanced primary hepatocellular carcinoma. China Cancer. 21:874\u2013876.","journal-title":"China Cancer"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.01030"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X18500507"},{"key":"e_1_3_4_52_1","first-page":"613","article-title":"Research about effect of the influence of Kang\u2019ai injection on the complement system and fibrosis state of patients with hepatic carcinoma","volume":"30","author":"Wei MQ.","year":"2015","unstructured":"Wei MQ. 2015. Research about effect of the influence of Kang\u2019ai injection on the complement system and fibrosis state of patients with hepatic carcinoma. Pract J Cancer. 30:613\u2013615.","journal-title":"Pract J Cancer"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v10.i11.799"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6305645"},{"key":"e_1_3_4_55_1","first-page":"1575","article-title":"Effect of Kangai injection on quality of life in patients with advanced hepatic cancers","volume":"19","author":"Yang RY","year":"2010","unstructured":"Yang RY, Zhang HW. 2010. Effect of Kangai injection on quality of life in patients with advanced hepatic cancers. Chin J New Drug. 19:1575\u20131577.","journal-title":"Chin J New Drug"},{"key":"e_1_3_4_56_1","first-page":"448","article-title":"Curative effect observation of Kangai injection in the treatment of liver cancer with portal vein cancer-thrombus","volume":"21","author":"Yao X","year":"2014","unstructured":"Yao X, Zhang DX, Yu CS. 2014. Curative effect observation of Kangai injection in the treatment of liver cancer with portal vein cancer-thrombus. Chin J Trad Med Sci Tech. 21:448\u2013449.","journal-title":"Chin J Trad Med Sci Tech"},{"key":"e_1_3_4_57_1","first-page":"997","article-title":"Clinical observation on the effect of Kang\u2019ai injection combined with transcatheter arterial chemoembolization on hepatocellular carcinoma in 36 patients","volume":"28","author":"Yi JZ","year":"2008","unstructured":"Yi JZ, Xie YC, Deng XH. 2008. Clinical observation on the effect of Kang\u2019ai injection combined with transcatheter arterial chemoembolization on hepatocellular carcinoma in 36 patients. Tumor. 28:997\u20131000.","journal-title":"Tumor"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.12141"},{"key":"e_1_3_4_59_1","first-page":"3363","article-title":"The clinical effect of entecavir combined with Kangai injection in the treatment of HBV related liver cancer after transcatheter arterial chemoembolization","volume":"24","author":"Zhang Y.","year":"2015","unstructured":"Zhang Y. 2015. The clinical effect of entecavir combined with Kangai injection in the treatment of HBV related liver cancer after transcatheter arterial chemoembolization. Modern J Integr Trad Chin West Med. 24:3363\u20133365.","journal-title":"Modern J Integr Trad Chin West Med"},{"key":"e_1_3_4_60_1","first-page":"88","article-title":"The application research of traditional Chinese medicine combined with TACE in the treatment of primary liver cancer","volume":"8","author":"Zhou HM","year":"2011","unstructured":"Zhou HM, Zhang AQ, Zhang ZH. 2011. The application research of traditional Chinese medicine combined with TACE in the treatment of primary liver cancer. China Health Industry. 8:88\u201389.","journal-title":"China Health Industry"},{"key":"e_1_3_4_61_1","first-page":"156","article-title":"Clinical curative effect observation of TACE combined with Kangai injection in the treatment of advanced primary liver cancer","volume":"8","author":"Zhu HX.","year":"2013","unstructured":"Zhu HX. 2013. Clinical curative effect observation of TACE combined with Kangai injection in the treatment of advanced primary liver cancer. China Pract Med. 8:156\u2013157.","journal-title":"China Pract Med"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021952"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28048"}],"container-title":["Pharmaceutical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13880209.2021.1915340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T16:13:36Z","timestamp":1711383216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13880209.2021.1915340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1080\/13880209.2021.1915340"],"URL":"https:\/\/doi.org\/10.1080\/13880209.2021.1915340","relation":{},"ISSN":["1388-0209","1744-5116"],"issn-type":[{"value":"1388-0209","type":"print"},{"value":"1744-5116","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}